| Financial Year |
March 31 2023 |
| Monetary Funds |
6,498,873,039.00 |
| Held-for-trading Financial Assets |
2,098,550,766.07 |
| Notes Receivable |
103,826,752.63 |
| Accounts Receivable |
6,535,368,915.56 |
| Advances to Suppliers |
1,128,552,429.69 |
| Other Receivables |
1,713,842,541.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
3,564,935.89 |
| Dividend Receivable |
323,358,913.40 |
| Inventories |
10,135,395,233.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
370,805,322.34 |
| Total Current Assets |
30,438,978,797.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
559,111,248.03 |
| Long-term Equity Investment |
13,967,845,324.13 |
| Investment Properties |
71,567,537.68 |
| Fixed Assetes |
3,669,431,686.12 |
| Under-construction Projects |
52,745,916.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,781,329,953.07 |
| R&D expenses |
1,246,894,374.48 |
| Goodwill |
95,608,195.09 |
| Long-Term Deferred and Prepaid Expenses |
47,553,654.28 |
| Deferred Income Tax Assets |
1,200,215,109.97 |
| Other Non-Current Assets |
1,128,331,863.50 |
| Sub-Total of Non-Current Assets |
25,511,853,486.19 |
| Total Assets |
55,950,832,283.19 |
| Short-Term Loans |
13,789,926,826.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
183,240,027.85 |
| Accounts Payable |
7,699,446,719.96 |
| Accounts Received In Advance |
39,374,268.51 |
| Employee Compensation Payable |
786,488,644.03 |
| Taxes Payable |
480,378,309.57 |
| Interest Payable |
-- |
| Dividend Payable |
3,165,161.88 |
| Other payables |
701,719,131.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,319,121,695.88 |
| Other Current Liabilities |
119,103,264.00 |
| Sub-Total of Current Liabilities |
30,780,177,647.27 |
| Long-term Loans |
3,141,040,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
16,248,145.63 |
| Special Payable |
-- |
| Estimatied Liabilities |
32,108,423.94 |
| Deferred Income Tax Liabilities |
41,408,296.24 |
| Other Non-Current Liabilities |
1,283,853,250.46 |
| Sub-Total of Non-Current Liabilities |
5,029,436,058.73 |
| Total Liabilities |
35,809,613,706.00 |
| Paid-In Capital(Or Share Stock) |
3,350,297,713.00 |
| Capital Surplus |
11,056,389,283.58 |
| Surplus Reserve |
1,324,875,027.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
683,511,292.12 |
| Minority Stockholder's Interest |
4,969,926,036.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,171,292,540.42 |
| Owner's Equity（Stockholder's Equity） |
20,141,218,577.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
55,950,832,283.19 |
